1. Home
  2. PBM vs CMND Comparison

PBM vs CMND Comparison

Compare PBM & CMND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PBM
  • CMND
  • Stock Information
  • Founded
  • PBM 1994
  • CMND 2017
  • Country
  • PBM Canada
  • CMND Canada
  • Employees
  • PBM 10
  • CMND N/A
  • Industry
  • PBM
  • CMND Biotechnology: Pharmaceutical Preparations
  • Sector
  • PBM
  • CMND Health Care
  • Exchange
  • PBM NYSE
  • CMND Nasdaq
  • Market Cap
  • PBM 5.3M
  • CMND 6.5M
  • IPO Year
  • PBM N/A
  • CMND N/A
  • Fundamental
  • Price
  • PBM $1.37
  • CMND $1.36
  • Analyst Decision
  • PBM
  • CMND
  • Analyst Count
  • PBM 0
  • CMND 0
  • Target Price
  • PBM N/A
  • CMND N/A
  • AVG Volume (30 Days)
  • PBM 526.0K
  • CMND 113.9K
  • Earning Date
  • PBM 02-02-2025
  • CMND 01-22-2025
  • Dividend Yield
  • PBM N/A
  • CMND N/A
  • EPS Growth
  • PBM N/A
  • CMND N/A
  • EPS
  • PBM N/A
  • CMND N/A
  • Revenue
  • PBM N/A
  • CMND N/A
  • Revenue This Year
  • PBM N/A
  • CMND N/A
  • Revenue Next Year
  • PBM N/A
  • CMND N/A
  • P/E Ratio
  • PBM N/A
  • CMND N/A
  • Revenue Growth
  • PBM N/A
  • CMND N/A
  • 52 Week Low
  • PBM $1.21
  • CMND $0.95
  • 52 Week High
  • PBM $323.25
  • CMND $2.30
  • Technical
  • Relative Strength Index (RSI)
  • PBM 37.76
  • CMND 50.25
  • Support Level
  • PBM $1.21
  • CMND $1.41
  • Resistance Level
  • PBM $1.59
  • CMND $1.50
  • Average True Range (ATR)
  • PBM 0.24
  • CMND 0.10
  • MACD
  • PBM 0.03
  • CMND -0.00
  • Stochastic Oscillator
  • PBM 17.53
  • CMND 42.86

About PBM PSYENCE BIOMEDICAL LTD

Psyence Biomedical Ltd is a life science biotechnology company pioneering the use of natural psychedelics in mental health and wellbeing. It develops natural psilocybin products for the healing of psychological trauma and its mental health consequences in the context of palliative care. The company has commenced the clinical trial process to evaluate the safety and efficacy of its product candidates. It cultivates natural psilocybin mushrooms at its federally licensed facility in Southern Africa. This product is produced for export to its partners across the world to be processed into a standardized encapsulated product.

About CMND Clearmind Medicine Inc.

Clearmind Medicine Inc is a psychedelic pharmaceutical biotech company focused on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and underserved health problems, including alcohol use disorder. Its primary objective is to research and develop psychedelic-based compounds and attempt to commercialize them as regulated medicines, foods, or supplements. The company's intellectual portfolio currently consists of four patent families. The company intends to seek additional patents for its compounds whenever warranted and will remain opportunistic regarding the acquisition of additional intellectual property to build its portfolio.

Share on Social Networks: